The most important thing to keep in mind when you look at Walgreens today is -- unfortunately-- its weak business performance ...

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

For the fiscal third quarter ended May 31, Walgreens posted adjusted earnings of 38 cents a share, topping the 25 cents analysts had expected. Sales of $39 billion surpassed the $37 billion Wall ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Walgreens Boots Alliance's fiscal third-quarter results came in above FactSet consensus estimates. Total revenue of $39 billion was up 7.2% year over year, and adjusted earnings per share declined ...

Walgreens Boots Alliance (WBA) closed at $11.16 in the latest trading session, marking a +0.95% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.58%.

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. While there's a potential turnaround opportunity for the business in the years ahead, that ...

In the latest market close, Walgreens Boots Alliance (WBA) reached $11.20, with a -0.44% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.41 ...